|
|
Belle-II DEPFET and PXD Collaboration(Ye, H. et al), Boronat, M., Esperante, D., Fuster, J., Gomis, P., Lacasta, C., et al. (2021). Commissioning and performance of the Belle II pixel detector. Nucl. Instrum. Methods Phys. Res. A, 987, 164875–5pp.
Abstract: The Belle II experiment at the SuperKEKB energy-asymmetric e(+)e(-) collider has completed a series of substantial upgrades and started collecting data in 2019. The experiment is expected to accumulate a data set of 50 ab(-1) to explore new physics beyond the Standard Model at the intensity frontier. The pixel detector (PXD) of Belle II plays a key role in vertex determination. It has been developed using the DEpleted P-channel Field Effect Transistor (DEPFET) technology, which combines low power consumption in the active pixel area and low intrinsic noise with a very small material budget. In this paper, commissioning and performance of the PXD measured with first collision data are presented.
|
|
|
|
Belle-II DEPFET and PXD Collaborations(Wang, B. et al), & Marinas, C. (2022). Operational experience of the Belle II pixel detector. Nucl. Instrum. Methods Phys. Res. A, 1032, 166631–7pp.
Abstract: The Belle II experiment at the SuperKEKB accelerator has started its physics data taking with the full detector setup in March 2019. It aims to collect 40 times more e+e- collision data compared with its predecessor Belle experiment. The Belle II pixel detector (PXD) is based on the Depleted P-channel Field Effect Transistor (DEPFET) technology. The PXD plays an important role in the tracking and vertexing of the Belle II detector. Its two layers are arranged at radii of 14 mm and 22 mm around the interaction point. The sensors are thinned down to 75 μm to minimize multiple scattering, and each module has interconnects and ASICs integrated on the sensor with silicon frames for mechanical support. PXD showed good performance during data taking. It also faces several operational challenges due to the high background level from the SuperKEKB accelerator, such as the damage from beam loss events, the drift in the HV working point due to radiation effect, and the impact of the high background.
|
|
|
|
NEXT Collaboration(Alvarez, V. et al), Carcel, S., Cervera-Villanueva, A., Diaz, J., Ferrario, P., Gil, A., et al. (2013). Near-intrinsic energy resolution for 30-662 keV gamma rays in a high pressure xenon electroluminescent TPC. Nucl. Instrum. Methods Phys. Res. A, 708, 101–114.
Abstract: We present the design, data and results from the NEXT prototype for Double Beta and Dark Matter (NEXT-DBDM) detector, a high-pressure gaseous natural xenon electroluminescent time projection chamber (TPC) that was built at the Lawrence Berkeley National Laboratory. It is a prototype of the planned NEXT-100 Xe-136 neutrino-less double beta decay (0 nu beta beta) experiment with the main objectives of demonstrating near-intrinsic energy resolution at energies up to 662 keV and of optimizing the NEXT-100 detector design and operating parameters. Energy resolutions of similar to 1% FWHM for 662 keV gamma rays were obtained at 10 and 15 atm and similar to 5% FWHM for 30 keV fluorescence xenon X-rays. These results demonstrate that 0.5% FWHM resolutions for the 2459 keV hypothetical neutrino-less double beta decay peak are realizable. This energy resolution is a factor 7-20 better than that of the current leading 0 nu beta beta experiments using liquid xenon and thus represents a significant advancement. We present also first results from a track imaging system consisting of 64 silicon photo-multipliers recently installed in NEXT-DBDM that, along with the excellent energy resolution, demonstrates the key functionalities required for the NEXT-100 0 nu beta beta search.
|
|
|
|
Alvarez, V., Herrero-Bosch, V., Esteve, R., Laing, A., Rodriguez, J., Querol, M., et al. (2019). The electronics of the energy plane of the NEXT-White detector. Nucl. Instrum. Methods Phys. Res. A, 917, 68–76.
Abstract: This paper describes the electronics of NEXT-White (NEW) detector PMT plane, a high pressure xenon TPC with electroluminescent amplification (HPXe-EL) currently operating at the Laboratorio Subterraneo de Canfranc (LSC) in Huesca, Spain. In NEXT-White the energy of the event is measured by a plane of photomultipliers (PMTs) located behind a transparent cathode. The PMTs are Hamamatsu R11410-10 chosen due to their low radioactivity. The electronics have been designed and implemented to fulfill strict requirements: an overall energy resolution below 1% and a radiopurity budget of 20 mBq unit(-1) in the chain of Bi-214. All the components and materials have been carefully screened to assure a low radioactivity level and at the same time meet the required front-end electronics specifications. In order to reduce low frequency noise effects and enhance detector safety a grounded cathode connection has been used for the PMTs. This implies an AC-coupled readout and baseline variations in the PMT signals. A detailed description of the electronics and a novel approach based on a digital baseline restoration to obtain a linear response and handle AC coupling effects is presented. The final PMT channel design has been characterized with linearity better than 0.4% and noise below 0.4 mV.
|
|
|
|
Amaldi, U., Bonomi, R., Braccini, S., Crescenti, M., Degiovanni, A., Garlasche, M., et al. (2010). Accelerators for hadrontherapy: From Lawrence cyclotrons to linacs. Nucl. Instrum. Methods Phys. Res. A, 620(2-3), 563–577.
Abstract: Hadrontherapy with protons and carbon ions is a fast developing methodology in radiation oncology. The accelerators used and planned for this purpose are reviewed starting from the cyclotrons used in the thirties. As discussed in the first part of this paper, normal and superconducting cyclotrons are still employed, together with synchrotrons, for proton therapy while for carbon ion therapy synchrotrons have been till now the only option. The latest developments concern a superconducting cyclotron for carbon ion therapy, fast-cycling high frequency linacs and 'single room' proton therapy facilities. These issues are discussed in the second part of the paper by underlining the present challenges, in particular the treatment of moving organs.
|
|
